These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38020606)

  • 21. Comparative effects of low-dose versus standard-dose alteplase in ischemic patients with prior stroke and/or diabetes mellitus: The ENCHANTED trial.
    Chen G; Wang X; Robinson TG; Pikkemaat M; Lindley RI; Zhou S; Ping L; Liu W; Liu L; Chalmers J; Anderson CS;
    J Neurol Sci; 2018 Apr; 387():1-5. PubMed ID: 29571842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Symptomatic Intracranial Hemorrhage With Tenecteplase vs Alteplase in Patients With Acute Ischemic Stroke: The Comparative Effectiveness of Routine Tenecteplase vs Alteplase in Acute Ischemic Stroke (CERTAIN) Collaboration.
    Warach SJ; Ranta A; Kim J; Song SS; Wallace A; Beharry J; Gibson D; Cadilhac DA; Bladin CF; Kleinig TJ; Harvey J; Palanikumar L; Doss VT; Marescalco R; Fink JN; Tyson A; Schlick KH; Noh L; Wilson D; Figueroa S; Pech MA; Paletz LB; Lewis MK; Castro M; Sahlein DH; Lafranchise EF; Sandall J; Asif KS; Geraghty SR; Cullis PA; Malisch T; Neill TA; LaMonte MP; Campbell BCV; Wu TY
    JAMA Neurol; 2023 Jul; 80(7):732-738. PubMed ID: 37252708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-dose alteplase for the management of acute ischemic stroke in South Asians: A systematic review on cost, efficacy and safety.
    Nepal G; Kharel S; Kumar Yadav J; Kumar Yadav S; Bhagat R; Ka Shing Y; Coghlan M; Lal Bhattarai S; Sigdel K; Chandra Mahat B
    J Clin Neurosci; 2022 Sep; 103():92-99. PubMed ID: 35853390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(13):1-214. PubMed ID: 34484487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes and Treatment Complications of Intravenous Urokinase Thrombolysis in Acute Ischemic Stroke in China.
    Zhang R; Wei H; Ren Y; Wu Y; Luo Y; Zhang L; Huo Y; Feng J; Monnier PP; Qin X
    Front Neurol; 2021; 12():685454. PubMed ID: 34322082
    [No Abstract]   [Full Text] [Related]  

  • 26. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2 × 2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatment.
    Huang Y; Sharma VK; Robinson T; Lindley RI; Chen X; Kim JS; Lavados P; Olavarría V; Arima H; Fuentes S; Nguyen HT; Lee TH; Parsons MW; Levi C; Demchuk AM; Bath PM; Broderick JP; Donnan GA; Martins S; Pontes-Neto OM; Silva F; Pandian J; Ricci S; Stapf C; Woodward M; Wang J; Chalmers J; Anderson CS;
    Int J Stroke; 2015 Jul; 10(5):778-88. PubMed ID: 25832995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-Dose vs Standard-Dose Alteplase in Acute Lacunar Ischemic Stroke: The ENCHANTED Trial.
    Zhou Z; Delcourt C; Xia C; Yoshimura S; Carcel C; Torii-Yoshimura T; You S; Malavera A; Chen X; Hackett ML; Woodward M; Chalmers J; Xu J; Robinson TG; Parsons MW; Demchuk AM; Lindley RI; Mair G; Wardlaw JM; Anderson CS
    Neurology; 2021 Mar; 96(11):e1512-e1526. PubMed ID: 33536271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and Safety of Recombinant Human Prourokinase in the Treatment of Acute Ischemic Stroke Within 4.5 Hours of Stroke Onset: A Phase 3 Randomized Clinical Trial.
    Song H; Wang Y; Ma Q; Feng W; Liu R; Lv X; Huang L; Li Y; Yang Y; Geng D; Zhu J; Wei Y; Chen H; Zhu R; Zhai Q; Guo J; Liu B; Zhao S; Wang Y;
    JAMA Netw Open; 2023 Jul; 6(7):e2325415. PubMed ID: 37490291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost effectiveness and budget impact of universal varicella vaccination in Russia.
    Marijam A; Safonova E; Scherbakov M; Shpeer E; Van Oorschot D; Rudakova A; Tatochenko V; Briko N
    Hum Vaccin Immunother; 2022 Nov; 18(5):2045152. PubMed ID: 35258445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is concurrent intravenous alteplase in patients undergoing endovascular treatment for large vessel occlusion stroke cost-effective even if the cost of alteplase is only US$1?
    Ospel JM; McDonough R; Kunz WG; Goyal M
    J Neurointerv Surg; 2022 Jun; 14(6):568-572. PubMed ID: 34187871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of Renal Impairment on Outcome for Thrombolysis-Treated Acute Ischemic Stroke: ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study) Post Hoc Analysis.
    Carr SJ; Wang X; Olavarria VV; Lavados PM; Rodriguez JA; Kim JS; Lee TH; Lindley RI; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Woodward M; Chalmers J; Anderson CS; Robinson TG;
    Stroke; 2017 Sep; 48(9):2605-2609. PubMed ID: 28739832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The IMPact of untReated nOn-Valvular atrial fibrillation on short-tErm clinical and economic outcomes in the US Medicare population: the IMPROVE-AF model.
    Sussman M; Di Fusco M; Tao CY; Guo JD; Gillespie JA; Ferri M; Adair N; Cato MS; Shirkhorshidian I; Barnes GD
    J Med Econ; 2021; 24(1):1070-1082. PubMed ID: 34415229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A full economic evaluation of extensive vaccination against rotavirus with RIX4414 vaccine at National and Regional level in Italy].
    Vitale F; Barbieri M; Dirodi B; Vitali Rosati G; Franco E
    Ann Ig; 2013; 25(1):43-56. PubMed ID: 23435779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of Blood Pressure Lowering and Alteplase Dose in Acute Ischemic Stroke: Results of the Enhanced Control of Hypertension and Thrombolysis Stroke Study.
    Wang X; Song L; Yang J; Sun L; Moullaali TJ; Sandset EC; Delcourt C; Lindley RI; Robinson TG; Minhas JS; Arima H; Chalmers J; Kim JS; Sharma V; Wang JG; Pontes-Neto O; Lavados PM; Olavarría VV; Lee TH; Levi C; Martins SO; Thang NH; Anderson CS;
    Cerebrovasc Dis; 2019; 48(3-6):207-216. PubMed ID: 31812956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The budget impact of adding pralsetinib to a US health plan formulary for treatment of non-small cell lung cancer and thyroid cancer with
    Duff S; Bargiacchi F; Norregaard C; Brener M; Sullivan E
    J Manag Care Spec Pharm; 2022 Feb; 28(2):218-231. PubMed ID: 34726500
    [No Abstract]   [Full Text] [Related]  

  • 37. Acute 'strokenomics': efficacy and economic analyses of alteplase for acute ischemic stroke.
    Quinn TJ; Dawson J
    Expert Rev Pharmacoecon Outcomes Res; 2009 Dec; 9(6):513-22. PubMed ID: 19941428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utilization of Intravenous Tissue Plasminogen Activator and Reasons for Nonuse in Acute Ischemic Stroke in Saudi Arabia.
    Al Khathaami AM; Al Bdah B; Tarawneh M; Alskaini M; Alotaibi F; Alshalan A; Almuhraj M; Aldaham D; Alotaibi N
    J Stroke Cerebrovasc Dis; 2020 May; 29(5):104761. PubMed ID: 32173225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Egyptian experience in increasing utilization of reperfusion therapies in acute ischemic stroke.
    Zakaria MF; Aref H; Abd ElNasser A; Fahmy N; Tork MA; Fouad MM; ElBokl A; Roushdy T; ElFaramawy S; El-Shiekh MA; Moustafa RR
    Int J Stroke; 2018 Jul; 13(5):525-529. PubMed ID: 28585904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Intravenous Thrombolytic Dose of Alteplase on Long-Term Prognosis in Patients with Acute Ischemic Stroke.
    Zhai M; Cao S; Yang J; Cao X; Dong Z; Liu W; Fu Y; Guan Q; Wang Y; Liu H
    Neurol Ther; 2023 Aug; 12(4):1105-1118. PubMed ID: 37166676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.